These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 839365)

  • 21. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketoacidosis in pancreatectomized man.
    Barnes AJ; Bloom SR; Goerge K; Alberti GM; Smythe P; Alford FP; Chisholm DJ
    N Engl J Med; 1977 Jun; 296(22):1250-3. PubMed ID: 404553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
    Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
    Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.
    Gerich JE; Langlois M; Noacco C; Karam JH; Forsham PH
    Science; 1973 Oct; 182(4108):171-3. PubMed ID: 4581053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon and growth hormone secretion in insulin-treated diabetics: effects of added sulfonylureas.
    Fallucca F; Iavicoli M; Menzinger G; Mirabella C; Andreani D
    Metabolism; 1978 Jan; 27(1):5-11. PubMed ID: 413023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis.
    Sherwin R; Wahren J; Felig P
    Metabolism; 1976 Nov; 25(11 Suppl 1):1381-3. PubMed ID: 979638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term of the artificial beta-cell (Biostator) on pancreatic glucagon response in insulin-dependent diabetic (IDDM).
    Ratzmann KP; Schneider U; Besch W; Heinke P
    Exp Clin Endocrinol; 1984 Jul; 84(1):91-8. PubMed ID: 6383851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon and diabetes. II. Complete suppression of glucagon by insulin in human diabetes.
    Warne GL; Alford FP; Chisholm DJ; Court J
    Clin Endocrinol (Oxf); 1977 Apr; 6(4):277-84. PubMed ID: 862206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.
    Sacca L; Hendler R; Sherwin RS
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1160-3. PubMed ID: 400737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin and glucagon secretion in streptozotocin-diabetic rats: influences of islets transplanted to the renal subcapsular space.
    Ar'Rajab A; Ahrén B; Bengmark S
    Diabetes Res; 1989 Sep; 12(1):37-41. PubMed ID: 2517050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of physical exercise on secretion of growth hormone, glucagon, and cortisol in obese and diabetic children.
    Garlaschi C; di Natale B; del Guercio MJ; Caccamo A; Gargantini L; Chiumello G
    Diabetes; 1975 Aug; 24(8):758-61. PubMed ID: 1158040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon response to arginine after treatment of diabetes mellitus.
    Ohneda A; Ishii S; Horigome K; Yamagata S
    Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs.
    Freyse EJ; Becher T; El-Hag O; Knospe S; Göke B; Fischer U
    Diabetes; 1997 May; 46(5):824-8. PubMed ID: 9133550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal alpha cell function in diabetics response to insulin.
    Unger RH; Madison LL; Muller WA
    Diabetes; 1972 May; 21(5):301-7. PubMed ID: 24683634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.